Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Losartan, sold under the brand name Cozaar among others, is a medication used to treat high blood pressure (hypertension). It is in the angiotensin receptor blocker (ARB) family of medication, and is considered protective of the kidneys. Besides hypertension, it is also used in diabetic kidney disease, heart failure, and left ventricular enlargement. It…
The analysis highlights Applications and Art as prominent areas in the source structure around Losartan.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Losartan shows recurring relationship patterns in the source. For example, Losartan → API, Between November, Camber Pharmaceuticals, FDA, Hetero Labs, Legacy Pharmaceutical Packaging, Macleods Pharmaceutical Limited, N-methylnitrosobutyric, N-nitroso-N-methyl-4-aminobutyric, N-nitrosodiethylamine, Sandoz, September, Teva Pharmaceuticals, Torrent Pharmaceuticals, Vivimed Life Sciences Another extracted example is Losartan → Al-Majed AR, Assiri, Clin Pharmacokinet, Clinical, Comprehensive Profile, Gehr TW, Ghosh, Khalil NY, PMID, Profiles Drug Subst Excip, Relat Methodol, S2CID, Sica DA. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
blood angiotensin may pressure medication effects ii kidney adverse receptor used use renin potassium pregnancy hypertension occur drug hours acid
TTTA extracted 104 structured relationships around Losartan. Examples in this analysis include Losartan → 3D model (JSmol) → Interactive image and Losartan → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Losartan | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Losartan | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Losartan | ATC code | C09CA01 (WHO) | 1.00 | infobox |
| Losartan | Bioavailability | 25–35% | 1.00 | infobox |
| Losartan | CAS Number | 114798-26-4 Y | 1.00 | infobox |
| Losartan | ChEBI | CHEBI:6541 Y | 1.00 | infobox |
| Losartan | ChEMBL | ChEMBL191 Y | 1.00 | infobox |
| Losartan | ChemSpider | 3824 Y | 1.00 | infobox |
| Losartan | CompTox Dashboard (EPA) | DTXSID7023227 | 1.00 | infobox |
| Losartan | Drug class | Angiotensin II receptor antagonist | 1.00 | infobox |
| Losartan | DrugBank | DB00678 Y | 1.00 | infobox |
| Losartan | ECHA InfoCard | 100.110.555 | 1.00 | infobox |
| Losartan | Elimination half-life | 1.5–2 hours | 1.00 | infobox |
| Losartan | Excretion | Kidney 13–25%, bile duct 50–60% | 1.00 | infobox |
| Losartan | Formula | C22H23ClN6O | 1.00 | infobox |
| Losartan | IUPHAR/BPS | 590 | 1.00 | infobox |
| Losartan | KEGG | D08146 Y | 1.00 | infobox |
| Losartan | Legal status | US: ℞-only | 1.00 | infobox |
| Losartan | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Losartan | License data | US DailyMed: Losartan | 1.00 | infobox |
| Losartan | MedlinePlus | a695008 | 1.00 | infobox |
| Losartan | Metabolism | Liver (CYP2C9, CYP3A4) | 1.00 | infobox |
| Losartan | Molar mass | 422.92 g·mol−1 | 1.00 | infobox |
| Losartan | Pregnancy category | AU: D | 1.00 | infobox |
| Losartan | Pronunciation | /loʊˈsɑːrtən/ ⓘ | 1.00 | infobox |
| Losartan | Protein binding | 99.7% (primarily albumin) | 1.00 | infobox |
| Losartan | PubChem CID | 3961 | 1.00 | infobox |
| Losartan | Routes of administration | By mouth | 1.00 | infobox |
| Losartan | Trade names | Cozaar, others | 1.00 | infobox |
| Losartan | UNII | JMS50MPO89 | 1.00 | infobox |
The concept neighborhoods around Losartan bring nearby vocabulary together. In this analysis, examples include Ii, Angiotensin and Receptor. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Losartan, one of the stronger structural bridges in this analysis connects Losartan with Adverse effects. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Losartan to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications & Art, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Losartan · EN edition · Analysis: TopicsToTalkAbout